Longhui Pharmaceutical Co., Ltd. announced that it will receive CNY 44,475,900 in an equity round of funding on July 25, 2020. The transaction will include participation from Zhangzhou Pientzehuang Pharmaceutical., Ltd. Pursuant to the transaction, the registered capital of the company will increase from CNY 100,000,000 to CNY 144,475,900. Post to the transaction and concurrent acquisition, the investor will hold 51% stake in the company.